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Chronic inflammatory bowel diseases (IBD) include ulcerative colitis (UC) and Crohn’s disease (CD), 
the etiologies of which are not certainly defined, 
and are hypothesized to be an interaction between 
environmental, genetic, and immunologic factors.1 
Recent studies show a gradually increasing rate of IBD 
in developing countries in Africa, South America, 
and Asia.1 There has been a reported increase in the 
incidence and prevalence of IBD in the West during 
the past 50 years, 120-200/100000 for ulcerative 
colitis and 50-200/100000 for Crohn’s disease (CD).1 
Inflammatory bowel disease patients usually suffer 
from mal-absorption and mal-digestion, especially 
in the flare-up phase of the disease when increased 
requirement and decreased food intake are reported. 
Nutritional deficiency and malnutrition have been 
documented in IBD patients notably in CD, which 
may lead to adverse outcomes.2 Vitamins B12, A, 
E, and D need to be monitored and supplemented. 
When a large amount of the small bowel is resected, 
all nutrients will be absorbed poorly.3 This case-control 
study was designed to measure and compare serum 
levels of vitamins A and E between IBD patients and a 
healthy normal population in northeastern Iran. Due to 
the large differences in feeding habits in different areas, 
the aim of this study was to compare the levels of these 
vitamins in the patients and healthy cases.
This case-control study was carried out from 
November 2011 to April 2012 in Golestan Province, 
Northern Iran. In this study, 94 pathologically 
confirmed IBD cases, and 94 healthy age and gender-
matched controls with no gastrointestinal problems 
over the previous 2 years were recruited. The inclusion 
criteria for IBD patients were based on clinical diagnosis 
and pathology, and the exclusion criteria were based on 
those who did not receive vitamin supplements in the 
last 6 months.
A fasting blood sample was taken. Measurement 
of vitamins A and E was carried out by the high-
performance liquid chromatography (HPLC) 
technique (KNAUER V 7057-3; Smartline pump 1000 
V 7603; Smartline UV Detector 2500 V 7604 and 
Smartline manager 5000 V 7602, (Berlin, Germany). 
Values of less than 30 µg/dl for vitamin A and 0.5µg/
dl for vitamin E were considered as deficiencies. Retinol 
acetate (Retinyl palmitate [all-trance-retinol palmitate]; 
Sigma LN 68F0645, St. Louis, MO, USA) was used as 
the internal standard with a  final concentration of 2 
µg/ml. 
To extract vitamins, 200 µl methanol (Merck & Co., 
Inc., Rahway, NJ, USA), 200 µl Ethanol (Merck & Co., 
Inc., Rahway, NJ, USA, 11727), 50 µl internal standard 
(Retinol acetate) and 500 µl n-Hexan (Merck & Co., 
Inc., Rahway, NJ, USA, 04391) were added to 200 µl of 
plasma. The surface phase was gathered after centrifuge 
and 500 µl n-Hexan added, and then vaporized by 
nitrogen gas. The remaining was dissolved in 200 µl 
methanol, and 50 µl of sample was injected for HPLC 
(flow rate: 1.5 ml/min, time: 20 min, sample: 50µl, 
wavelength [0 min–7 min]: 325 nm, wavelength [7 min 
-15 min]: 292 nm)]. The ethical committee of Golestan 
University of Medical Sciences (No=1453) approved 
this study, and the patient  consents were obtained.
Fifty percent of both case and control groups were 
male. The mean (standard deviation [SD]) age of patients 
was 38 (15), and of controls was 38 (14) years (p=0.8). 
Disclosure. The authors declare no affiliation or financial 
involvement with organizations or entities with a direct 
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Table 1 - The mean (standard deviation) levels of vitamins A and E in 
inflammatory bowel disease patients and controls in different 
age and gender groups.
Variable Vitamin  E P-value Vitamin A P-value
Group
  Case 0.40 (0.37)
  0.001*
46.85 (32.23)
 0.03*
  Control 1.29 (1.80) 58.25 (27.56)
Gender
  Male 0.87 (1.31)
0.21*
54.46 (29.82)
 0.42*
  Female 0.82 (1.43) 50.26 (31.23)
Age group
  <29 years 0.57 (1.03)
    0.001**
50.51 (26.13)
0.3**  30-42 years 0.56 (1.03) 51.92 (33.14)
  >43 years 1.41 (1.76) 54.82 (32.76)
*Student t-test, **One-way ANOVA
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The mean level of vitamin A was not significantly 
different between males and females (p=0.42) as well 
as different age groups (p=0.3) (Table 1). The vitamin E 
level was not significantly different between the genders 
(p=0.21). The levels of vitamin E were significantly 
higher in older (> 43 years) compared with other age 
groups (p=0.001) (Table 1). Vitamin A had no significant 
relationship with age (p=0.24). There was no significant 
difference in proportion of vitamin A (p=0.4) and E 
(p=0.32) deficiencies between males and females in the 
control group. In the IBD group, the proportions of 
vitamin A deficiency were 22.7% in males, and 43.6% 
in females (p=0.04), and regarding vitamin E deficiency, 
they were 65.5% in males, and 78.7%, in females 
(p=0.1). The means of both vitamins A (p=0.03) and 
E (p=0.001) were significantly lower in IBD cases than 
controls (Table 1). In this study, 32.5% of patients and 
18.2% of controls had vitamin A deficiency (p=0.03). 
Vitamin E deficiency was seen in 72% of IBD cases, and 
46% of controls (p=0.001). The duration of disease in 
those with vitamin A deficiency was 3.3 years, and 2.9 
years in those with normal levels of vitamin A (p=0.21). 
These values were 3.9 years in those with vitamin E 
deficiency, and 2.9 years in those with normal vitamin 
E levels (p=0.18). No significant relationship was found 
between the duration of disease and the proportion of 
vitamin deficiencies in IBD patients.
In the present study, the serum levels of vitamin A 
and E were significantly lower in IBD patients compared 
with healthy controls. This finding was similar to some 
other investigations. Vagianos et al2 evaluated 126 
consecutive adults with IBD regarding biochemical 
markers of nutrition, and concluded that even if the 
nutritional status of the IBD patient seems well, vitamin 
and mineral deficiencies may exist. They showed a high 
proportion of deficiency for some nutrients, including 
vitamin E (63%), vitamin D (36%), vitamin A (26%), 
calcium (23%), folate (19%), iron (13%), and vitamin 
C (11%). They suggested a routine multivitamin 
supplementation in IBD patients. 
In the study of Alkhouri et al,4 they investigated 
the prevalence of vitamin and zinc deficiencies in 
patients with newly diagnosed IBD in comparison with 
a control group. This was a retrospective chart review 
of all patients diagnosed with IBD from 2006-2010, 
ages 1-18 years. A total of sixty-one IBD patients, 
and sixty-one age and gender-matched controls were 
included. None of the sixty-one patients with IBD 
had folate or vitamin B12 deficiency. Vitamin D 
deficiency was found in 62% of the patients, vitamin 
A deficiency in 16%, vitamin E deficiency in 5%, 
and zinc deficiency in 40%. The control group had 
vitamin D in 75%, vitamin E deficiency in 8%, and 
zinc deficiency in 19%. They concluded that vitamin 
B12 and folate deficiencies are rare in children with 
newly diagnosed the ulcerative colitis (UC). Vitamin A, 
and zinc deficiency are common in patients with newly 
diagnosed IBD and levels should be assessed at the time 
of diagnosis so that internal repletion can commence. 
Vitamin D deficiency is common in all children in the 
Buffalo, New York area and routine screening for this 
deficiency is warranted.4
In the study of Vavricka et al,5 it was shown that 
vitamin B(12) and folic acid supplementation may 
be necessary in IBD patients, especially those with 
CD with either inflammation of the terminal ileum 
or after resection of the terminal ileum. It is also 
recommended during therapy with sulfasalazine as 
this compound inhibits the absorption of vitamin 
B(12). They investigated that patients with high or 
continuous inflammatory CD activity and frequent 
therapy with steroids have an increased risk of low 
bone mineral density and vitamin D deficiency. These 
should be monitored regularly, and vitamin D should 
be supplemented. In a recent trial5 a trend towards a 
reduced risk of relapses in CD patients treated with 
vitamin D was reported. Only limited studies and case 
reports exist on other vitamin deficiencies, for example 
vitamins A, B(1), B(2), niacin, B(6), C, E, and K, found 
in IBD patients. Regular nutritional monitoring in IBD 
patients is warranted and requires the special attention 
of treating physicians and dieticians.5 
The limitation of this study was that the degree 
of severity of illness was unknown. If there were 
information on the severity of disease in comparison 
with the vitamin levels, better results could have been 
obtained.
In conclusion, we found vitamin A and E 
deficiencies in IBD patients. It may be concluded that 
without maintaining the optimum level of vitamins in 
IBD patients, they would be trapped in a cycle of low 
vitamin level, increased oxidant factors, increased tissue 
injury in the intestine, and again, further decrease in 
vitamin levels. A cohort study design is recommended, 
in addition to controlling the levels of vitamins, other 
micronutrients should also be evaluated and compared 
with the severity and progression or remission of disease.
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